tiprankstipranks
Sionna Therapeutics, Inc. (SION)
NASDAQ:SION
US Market
SION
Sionna Therapeutics, Inc.
RESEARCH TOOLSreports
Want to see SION full AI Analyst Report?

Sionna Therapeutics, Inc. (SION) Stock News & Sentiment

25 Followers
SION Earnings this Week: How Will it Perform?
Premium
Pre-Earnings
SION Earnings this Week: How Will it Perform?
2M ago
SION
Multiple Shots on Goal in Cystic Fibrosis: Sionna’s NBD1-Targeted Pipeline and 2026 Clinical Readouts Drive Buy Thesis and $58 DCF-Based Target
Premium
Ratings
Multiple Shots on Goal in Cystic Fibrosis: Sionna’s NBD1-Targeted Pipeline and 2026 Clinical Readouts Drive Buy Thesis and $58 DCF-Based Target
4M ago
SION
Sionna Therapeutics: NBD1-Targeted CFTR Stabilization Strategy Positions Pipeline for Best-in-Class Efficacy and Blockbuster Upside in Cystic Fibrosis
Premium
Ratings
Sionna Therapeutics: NBD1-Targeted CFTR Stabilization Strategy Positions Pipeline for Best-in-Class Efficacy and Blockbuster Upside in Cystic Fibrosis
4M ago
SION
BTIG Assigns Buy Rating to Sionna Therapeutics, Citing Innovative Cystic Fibrosis Therapies and Strong Market Potential
Premium
Ratings
BTIG Assigns Buy Rating to Sionna Therapeutics, Citing Innovative Cystic Fibrosis Therapies and Strong Market Potential
6M ago
SION
Sionna Therapeutics: Promising Developments and Strategic Advancements Boost Price Target
Premium
Ratings
Sionna Therapeutics: Promising Developments and Strategic Advancements Boost Price Target
6M ago
SION
Sionna Therapeutics Advances CF Pipeline Amid Strong Financials
Premium
Company Announcements
Sionna Therapeutics Advances CF Pipeline Amid Strong Financials
6M ago
SION
Sionna Therapeutics Advances Cystic Fibrosis Treatment with New Study
Premium
Company Announcements
Sionna Therapeutics Advances Cystic Fibrosis Treatment with New Study
6M ago
SION
More SION News >

SION News on the Web

Why Sionna Therapeutics Stock Is Sliding After a Surge
TipRanks News
Bullish
Sionna Chief Legal Officer Cashed Out Her Shares. Her Options Are Another Story
The Motley Fool
Neutral
Three new option listings on March 17th
TipRanks News
Neutral
SION Earnings this Week: How Will it Perform?
TipRanks News
Neutral
This Investor Sold $5 Million of a Biotech Stock Up 118% in a Year, but Here's Why It Still Seems Bullish on Shares
The Motley Fool
Bullish
Analysts Offer Insights on Healthcare Companies: Sionna Therapeutics, Inc. (SION) and Health Catalyst (HCAT)
TipRanks News
Bullish
Analysts Are Bullish on These Healthcare Stocks: Sionna Therapeutics, Inc. (SION), Privia Health Group (PRVA)
TipRanks News
Bullish
Analysts Offer Insights on Healthcare Companies: GH Research (GHRS) and Sionna Therapeutics, Inc. (SION)
TipRanks News
Bullish

News Score - Last 7 Days

Neutral
SION
Sector Average
Media Buzz
This Week1 articles
Weekly Average0.75 articles
News Sentiment
This Week100%
Sector Average70%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is SION’s Media Buzz Sentiment?
1 articles about SION were published this week. In an average week, 0.75 articles are published.
    What is SION’s weekly average amount of articles?
    In an average week, 0.75 articles about SION are published.
      What is SION’s News Sentiment?
      100% of articles about SION were positive this week, compared to its sector average of 70%.
        Healthcare Stocks that are Trending in the News
        TVTXTravere Therapeutics
        HVOOpen Orphan Plc
        PBMPsyence Biomedical
        QDELQuidelOrtho
        Showing the stocks with the most bullish news sentiment over the past week